Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Khiron Life Sciences Corp. (TSXV: KHRN) announced on August 7th that the company has entered into a non-binding agreement to acquire the issued and outstanding shares of the Latin American Institute of Neurology and the Nervous System (ILANS).

ILANS is one of the largest health service providers in Colombia. The Bogata clinic network provides healthcare services to an approximate 100,000 patients.

The gained revenue for Khiron after the acquisition closes is estimated at $10.5 million.